VectivBio, a clinical-stage biotechnology company developing transformational medicines for patients with serious rare diseases, has entered into a loan agreement with Kreos Capital, a global growth lender to life sciences and healthcare companies, granting VectivBio
Galenica, network operators of pharmacies in Switzerland and is a provider of pre-wholesale and wholesale distribution services in the Swiss healthcare market, and Medicall, medical services providers, are establishing a joint venture, Emeda, to provide
Usr Unité de Secours Régional, a company in the field of rescue, medical transfers and the provision of paramedical services in the canton of Vaud. As of 28 March 2022, became part of TCS Swiss Ambulance
Vokus Personal, a recruitment agency specializing in the placement of healthcare professionals in Switzerland, has been acquired by Storskogen, a Swedish investment company. Storskogen has acquired a 90 percent stake from Vokus Personal shareholders. Founded in 2012,
Eppendorf, a life science company that develops, produces and distributes products and services for the use in laboratories worldwide, made an investment in BigOmics Analytics, a Swiss biodata analytics start-up company, as part of their
The two former shareholders, Shayesteh Fürst-Ladani und Walter Fürst, have sold 100% of the shares in all SFL group companies with their registered seats in Switzerland (SFL Regulatory Affairs & Scientific Communication und SFL
The Otto Group, an international trading and service company, has acquired a majority stake in Medgate Holding. Otto Group became the new majority shareholder of Medgate Holding by subscribing to all the new shares created
Aison Technologies, developing and building tools to accelerate ultrasound procedures and increase diagnostic returns, closed its first seed financing round of CHF 850k. Partner Michael Baier (venture capital / m&a, pictured) and associate
Helsinn Group (Helsinn), a fully integrated, global biopharma company with a diversified pipeline of innovative oncology assets and strong track-record of commercial execution, and BridgeBio Pharma (BridgeBio), a commercial-stage biopharmaceutical company that focuses on genetic
The team included partners Matthias Courvoisier (pictured), Ludovico Rusconi (Milan), associate Beau Visser, trainee lawyer Vinzenz Sutter and Ladislas von Sury d'Aspremont.
